Download Sample
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....
Swine Vaccines Market: By Vaccine Type, By Disease Type, By Distribution Channel, and Region Forecast 2019-2030
Swine Vaccines Market: By Vaccine Type, By Disease Type, By Distribution Channel, and Region Forecast 2019-2030
Swine Vaccines Market size was expected to be valued at US$ 1,632.1 million in 2023 and is expected to grow at a CAGR of 5.1% from 2024 to 2030. The global market provides a detailed overview of the market and which can be segmented by vaccine type, disease type, distribution channel, and region. By vaccine type, the market has been segmented into inactivated vaccines, recombinant vaccines, live attenuated vaccines, DNA vaccines, subunit vaccines, and others. By vaccine type, the inactivated vaccines segment dominated the market and registered for having a significant revenue share of XX% during 2023-2029 owing to its easy availability, reasonable cost, and stability advantages over live-attenuated vaccines. Also, it minimizes the risk of virulence reversion after vaccination, as it prevents the replication process of pathogens.
Furthermore, it offers swine better immunization with a rapid cell-mediated immune response. Immunity obtained from inactivated vaccines can be further improved with adjuvants such as certain types of oils or aluminum hydroxide. By disease type, the swine vaccine market has been segmented into viral infections, bacterial infections, parasitic infections, fungal infections, and others. By disease type, the viral infections segment held the largest revenue share of the market in the past few years and is projected to have a rapid growth rate over the forecasted period due to continuous increasing viral infections among a large part of the population due to various swine diseases. Based on the distribution channel, the segment has been segregated into veterinary hospitals, veterinary pharmacies, and online pharmacies. The online pharmacies segment is expected to lead the distribution channel segments during the forecasted period with a significant market share.
Study Period
2025-2031Base Year
2024CAGR
5.1%Largest Market
Asia-PacificFastest Growing Market
Europe
Rising swine disease outbreaks primarily drive the market. Also, some highly contagious swine diseases such as porcine reproductive and respiratory syndrome (PRRS) and swine influenza remain to be increasing in prevalence among swine herds in Asia, Europe, and American regions contributing to severe economic loss. Thus, to curb the effect swine producers are widely implementing biosecurity measures and vaccination processes. These factors will expect to expand the swine vaccines market globally in the upcoming few years.
Asia Pacific accounted for the largest revenue share of about 45% in 2021 and is expected to register a significant CAGR during the forecast period owing to the presence of leading swine production countries such as China coupled with a large meat-consuming population and extensive range of requirement for vaccines to curb current rising disease outbreaks among Asian swine herds. Additionally, Asia had the largest pig population of 462.6 million pigs in 2021, among which China leads with around 347 million pigs, which surely spread the swine diseases, resulting in expanding the market of swine vaccines globally.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2023 |
US$ 1,632.1 million |
|
Market CAGR |
5.1% |
|
By Vaccine Type |
|
|
By Disease Type |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
Swine vaccines market size was expected to be valued at US$ 1,632.1 million in 2023 and is expected to grow at a CAGR of 5.1% from 2024 to 2030.
The major factors driving the market growth are the increasing prevalence of diseases in swine, the upsurges in the demand for animal protein, and the advancement in vaccination services.
Increasing awareness about the importance of animal health and the rising demand for meat & poultry products are expected to drive market growth.
| 1.Executive Summary |
| 2.Global Swine Vaccines Market Introduction |
| 2.1.Global Swine Vaccines Market - Taxonomy |
| 2.2.Global Swine Vaccines Market - Definitions |
| 2.2.1.Vaccine Type |
| 2.2.2.Disease Type |
| 2.2.3.Distribution Channel |
| 2.2.4.Region |
| 3.Global Swine Vaccines Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Swine Vaccines Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Swine Vaccines Market By Vaccine Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Inactivated Vaccines |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Recombinant vaccines |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Live attenuated vaccines |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. DNA vaccines |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Subunit vaccines |
| 5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6.Global Swine Vaccines Market By Disease Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Viral Infections |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Bacterial Infections |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Parasitic Infection |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Fungal Infections |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Swine Vaccines Market By Distribution Channel, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Veterinary Hospitals |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Veterinary Pharmacies |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Online Pharmacies |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Swine Vaccines Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Swine Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Vaccine Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Inactivated Vaccines |
| 9.1.2.Recombinant vaccines |
| 9.1.3.Live attenuated vaccines |
| 9.1.4.DNA vaccines |
| 9.1.5.Subunit vaccines |
| 9.1.6.Others |
| 9.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Viral Infections |
| 9.2.2.Bacterial Infections |
| 9.2.3.Parasitic Infection |
| 9.2.4.Fungal Infections |
| 9.2.5.Others |
| 9.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Veterinary Hospitals |
| 9.3.2.Veterinary Pharmacies |
| 9.3.3.Online Pharmacies |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Swine Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Inactivated Vaccines |
| 10.1.2.Recombinant vaccines |
| 10.1.3.Live attenuated vaccines |
| 10.1.4.DNA vaccines |
| 10.1.5.Subunit vaccines |
| 10.1.6.Others |
| 10.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Viral Infections |
| 10.2.2.Bacterial Infections |
| 10.2.3.Parasitic Infection |
| 10.2.4.Fungal Infections |
| 10.2.5.Others |
| 10.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Veterinary Hospitals |
| 10.3.2.Veterinary Pharmacies |
| 10.3.3.Online Pharmacies |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Swine Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Inactivated Vaccines |
| 11.1.2.Recombinant vaccines |
| 11.1.3.Live attenuated vaccines |
| 11.1.4.DNA vaccines |
| 11.1.5.Subunit vaccines |
| 11.1.6.Others |
| 11.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Viral Infections |
| 11.2.2.Bacterial Infections |
| 11.2.3.Parasitic Infection |
| 11.2.4.Fungal Infections |
| 11.2.5.Others |
| 11.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Veterinary Hospitals |
| 11.3.2.Veterinary Pharmacies |
| 11.3.3.Online Pharmacies |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Swine Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Inactivated Vaccines |
| 12.1.2.Recombinant vaccines |
| 12.1.3.Live attenuated vaccines |
| 12.1.4.DNA vaccines |
| 12.1.5.Subunit vaccines |
| 12.1.6.Others |
| 12.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Viral Infections |
| 12.2.2.Bacterial Infections |
| 12.2.3.Parasitic Infection |
| 12.2.4.Fungal Infections |
| 12.2.5.Others |
| 12.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Veterinary Hospitals |
| 12.3.2.Veterinary Pharmacies |
| 12.3.3.Online Pharmacies |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Swine Vaccines Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Inactivated Vaccines |
| 13.1.2.Recombinant vaccines |
| 13.1.3.Live attenuated vaccines |
| 13.1.4.DNA vaccines |
| 13.1.5.Subunit vaccines |
| 13.1.6.Others |
| 13.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Viral Infections |
| 13.2.2.Bacterial Infections |
| 13.2.3.Parasitic Infection |
| 13.2.4.Fungal Infections |
| 13.2.5.Others |
| 13.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Veterinary Hospitals |
| 13.3.2.Veterinary Pharmacies |
| 13.3.3.Online Pharmacies |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Zoetis (Pfizer, Inc.) (U.S.) |
| 14.2.2.Merck & Co. Inc. (U.S) |
| 14.2.3.Virbac S.A. (France) |
| 14.2.4.Boehringer Ingelheim Vetmedica (Germany) |
| 14.2.5.Elanco (U.S.) |
| 14.2.6.Bayer Animal Health (Germany) |
| 14.2.7.Ceva Sante Animale (France) |
| 14.2.8.Wilbur-Ellis Feed, LLC (U.S.) |
| 14.2.9.Vetoquinol S.A. (France) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.